Valiant Evo US Clinical Trial
A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 100 participants.
Also called NCT02652949
- Study
- In this atlas
Overview
- Design
- Interventional study; allocation not applicable; no masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 100 participants
- Sponsor
- Registry
-
NCT02652949
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Results first posted
- Countries
- United States
- Registry status
- Completed
Technical summary
Registry record NCT02652949. Allocation not applicable; no masking; primary purpose treatment. Start 2016-04 (actual); primary completion 2017-12 (actual). Results posted on 2019-02-26.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Valiant Evo US Clinical Trial
- Acronym
- VEVO
- Condition
- Aortic Aneurysm, Thoracic
- Intervention (Device)
- Valiant Evo Thoracic Stent Graft System
- Lead sponsor
- Medtronic Cardiovascular
Record details
- Record id
cardio:ct-nct02652949- Content hash
bc1d8a056460e9787d81397703f130b7c735d49cfe969177f1f1b1aa7ac35a18